The Antibiotic Resistance Status of Gram-negative Bacilli causing Hospitalized Pneumonia Directly Detected by the MPL real-time PCR to Detect the Antibiotic Resistance Genes
Huong Thien Pham1,2,3*, Van Hung Pham1,2, Duy Khanh Tran1,2, Quoc Viet Nguyen1,2
1Vietnam Research and Development Institute of Clinical Microbiology, Ho Chi Minh city 70000, Vietnam; 2NK-Biotek Co.;
3Pham Ngoc Thach University of Medicine, Ho Chi Minh city 70000, Vietnam
The causative agents of pneumonia requiring hospitalization are often Gram-negative bacilli, and this presents a challenge in treatment because Gram-negative bacilli, especially A. baumannii, P. aeruginosa, K. pneumoniae, and E. coli, have a relatively high rate of antibiotic resistance, including to potent and broad-spectrum antibiotics such as third and fourth generation cephalosporins and carbapenems[1,2,3].
To investigate the antibiotic resistance of Gram-negative bacilli causing hospital-acquired pneumonia, utilizing the multiplex realtime PCR (MPL-rPCR) assay developed by the Vietnam Institute of Clinical Microbiology Research and Development (VCM).
|
We conducted a five-year retrospective analysis of 15,936 respiratory clinical samples from hospitalized patients. The workflow of viral detection using an in-house MLP-rPCR assay targeting 17 respiratory viruses is shown below. |
Figure 1: Workflow used to detect pathogens and antibiotic-resistant genes using MPL-rPCR |
| Table 1: Pathogens detected by the MPL-rPCR developed by the VCM
|
Table 2: Antibiotic resistant genes detected directly from the samples by the MPL-rPCR developed by the VCM
|

1. Principe, L., Lupia, T., Andriani, L., Campanile, F., Carcione, D.,Corcione, S., … & Di Bella, S.(2022). Microbiological, clinical, and PK/PD features of the new anti-Gram-negative antibiotics: β-lactam/β-lactamase inhibitors in combination and cefiderocol—an all-inclusive guide for clinicians. Pharmaceuticals, 15(4), 463.2.
2. Hall, B. G., & Barlow, M. (2005). Revised Ambler classification of β-lactamases. Journal of Antimicrobial Chemotherapy, 55(6), 1050-1051.
3. Banerjee R, Patel R. Molecular diagnostics for genotypic detection of antibiotic resistance: current landscape and future directions. JAC Antimicrob Resist. 2023 Feb 17;5(1):dlad018. doi: 10.1093/jacamr/dlad018. PMID: 36816746; PMCID: PMC9937039.
